Exelixis Inc at Piper Sandler Healthcare Conference Transcript
Okay. Great. Maybe we'll go ahead and get started here. Thanks, everybody, for joining us or tuning in here at Piper Sandler's Annual Healthcare Conference. I'm Joe Catanzaro, one of the Piper's biotech analyst. It's my pleasure to kick off this section with Exelixis. Joining us is their SVP of Strategy, Andrew Peters. Andrew, thanks so much for joining us.
Questions & Answers
Maybe we could just sort of jump right into questions here and start off with a high level one. I know there's been a lot of recent effort at Exelixis around sort of building up the pipeline and diversifying away from cabo. So maybe you could speak to the overall strategy for the pipeline, what you see as the most capital efficient way to bring those assets into the clinic and establish proof of concept, and then maybe we could sort of tick through some assets
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
